![Testing Information Testing Information](https://webarchive.library.unt.edu/eot2008/20090202053341im_/http://ntp.niehs.nih.gov/images/template/subMastHead_testingInformation.gif)
Descriptions of NTP Study Types
Descriptions of NTP Study Types
Home » Testing Information » Descriptions of NTP Study Types » Alternative Models in Toxicity Research » Report Listings » GMM-10 - Abstract
Chemical Formula: C7H14N2 - Molecular Weight: 126.20
Diisopropylcarbodiimide is used as a reagent for a variety of reactions including peptide syntheses. The National Cancer Institute nominated diisopropylcarbodiimide for study as a representative chemical in the alkylcarbodiimide class because of its acute toxicity, widespread low-level human exposure, and the absence of data on health effects. Female Tg.AC hemizygous or p53 haploinsufficient mice were administered diisopropylcarbodiimide (greater than 99% pure) dermally for 20 or 27 weeks, respectively.
20-WEEK STUDY IN Tg.AC HEMIZYGOUS MICE
Groups of 10 female Tg.AC hemizygous mice received dermal applications of 0, 4.38, 8.75, 17.5, 35, or 70 mg diisopropylcarbodiimide/kg body weight in ethanol, 5 days a week for 20 weeks. Twelve animals died or were sacrificed moribund prior to the end of the study; two each from vehicle controls, 4.38, 8.75, and 17.5 mg/kg groups, and four from the 35 mg/kg group. Premature deaths were not associated with chemical-related lesions. Odontoma, a common spontaneous finding in Tg.AC hemizygous mice, resulting in jaw malformation, malocclusion, and loss of body condition, occurred in the majority of control, 4.38, 8.75, and 17.5 mg/kg animals that died prematurely. Of the surviving animals, mean body weights were similar to those of vehicle controls. There were no significant changes in organ weights and no treatment-related clinical findings. No neoplasms or nonneoplastic lesions were attributed to administration of diisopropylcarbodiimide.
27-WEEK STUDY IN p53 HAPLOINSUFFICIENT MICE
Groups of 15 female p53 haploinsufficient mice received dermal applications of 0, 4.38, 8.75, 17.5, 35, or 70 mg/kg diisopropylcarbodiimide in ethanol, 5 days a week for 27 weeks. All animals survived to the end of the study. Mean body weights were similar to those of vehicle controls, and there were no treatment-related clinical findings. At necropsy there were no treatment-related gross lesions. Microscopically, there was a higher incidence of treatment-related, predominantly minimal epidermal hyperplasia at the site of application in 70 mg/kg mice than in vehicle controls. No neoplasms were attributed to the administration of diisopropylcarbodiimide.
CONCLUSIONS
Under the conditions of this 27-week study, there was no evidence of carcinogenic activity of diisopropylcarbodiimide in female p53 haploinsufficient mice administered 4.38, 8.75, 17.5, 35, or 70 mg/kg in ethanol.
There were no treatment-related neoplasms or nonneoplastic lesions in female Tg.AC hemizygous mice administered 4.38, 8.75, 17.5, 35, or 70 mg/kg in ethanol for 20 weeks.
Synonyms: 1,3-Diisopropylcarbodiimide; N,N'-diisopropylcarbodiimide; N,N'-methanetetraylbis (2-propanamine)
Summary of the 20-Week Toxicology Study of Diisopropylcarbodiimide in Female Tg.AC Hemizygous Mice |
||||
---|---|---|---|---|
Doses in ethanol by dermal application |
Vehicle control, 4.38, 8.75, 17.5, 35, and 70 mg/kg |
|||
Body weights | Exposed groups similar to the vehicle control group | |||
Survival rates | 8/10, 8/10, 8/10, 8/10, 6/10, 10/10 | |||
Nonneoplastic effects | None | |||
Neoplastic effects | None | |||
Summary of the 27-Week Carcinogenesis Study of Diisopropylcarbodiimide in Female p53 Haploinsufficient Mice |
||||
---|---|---|---|---|
Doses in ethanol by dermal application |
Vehicle control, 4.38, 8.75, 17.5, 35, and 70 mg/kg |
|||
Body weights | Exposed groups similar to the vehicle control group | |||
Survival rates | 15/15, 15/15, 15/15, 15/15, 15/15, 15/15 | |||
Nonneoplastic effects | Skin: epidermal hyperplasia (0/15, 0/15, 0/15, 0/15, 0/15, 8/15) | |||
Neoplastic effects | None | |||
Level of evidence of carcinogenic activity | No evidence | |||
Report Date: March 2007
Pathology Tables, Survival and Growth Curves from NTP GMM Studies
Target Organs & Incidences from GMM Studies
You may link to the full study report in pdf format ( Note: A print ready copy of the document is presented in Portable Document Format (pdf) which requires the Acrobat Reader plug-in -- download a free copy of the reader.)
Web page last updated on April 19, 2007
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.